NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Supreme Industries Reports Strong Quarterly EBITDA Growth

Supreme Industries (SI) has reported a strong set of quarterly results, despite a lower-than-expected performance. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) growth for the fourth quarter of FY26 (4QFY26) witnessed a significant increase of approximately 50% compared to a dip in the first nine months of FY26 (9MFY26).

The main driver behind this improvement was a 34% rise in EBIT/kg (Earnings Before Interest and Taxes per kilogram) to INR22, primarily due to inventory gains of around INR0.7-0.8 billion and operating leverage. Additionally, the company witnessed a substantial rise in plastic pipe volume of approximately 18% year-over-year (YoY).

Looking ahead, management has guided piping volume growth at around 15-17% for FY27. Based on this positive outlook, analysts expect SI to achieve a 16% compound annual growth rate (CAGR) in revenue, 20% CAGR in EBITDA, and 23% CAGR in profit after tax (PAT) over FY26-28.

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

Revenue/EBITDA/PAT CAGR Projections for Supreme Industries

MetricFY26-28 CAGR
Revenue16%
EBITDA20%
PAT23%

The research report by Motilal Oswal values the stock at 37 times the estimated earnings per share (EPS) for FY28, resulting in a target price (TP) of INR4,320. In light of this analysis, the brokerage firm reiterates its BUY rating for Supreme Industries.

Investor Takeaway

Investors should consider buying Supreme Industries stock, targeting a price of Rs 4320.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.